Trypanosoma cruzi is the etiological agent of Chagas disease, a debilitating disease that affects about
18 million people [1], causing the deaths of 45,000 patients annually [2]. The current
treatment for this infection is very limited, and available drugs (Nifurtimox and
Benznidazole) have many side effects [3]. Several studies of crude plant extracts
have identified potential compounds to treat this disease. In this study was evaluated
the effect of piperovatine and piperlonguminine isolated from Piper ovatum Vahl on epimastigote form of T. cruzi, in LIT medium during 5 days. Ultrastructural and morphological alterations were
observed by electron microscopy. The piperovatine and piperlonguminine concentration
which inhibit 50% of growth (IC50) of epimastigotes were 11.5µg/ml and 17.0µg/ml, respectively. Epimastigotes treated
with piperovatine were fixed with 2.5% glutaraldehyde. For transmission electron microscopy,
cells were post-fixed in osmium tetroxide, dehydrated in acetone, and embedded in
Epon. Ultrathin sections were observed in Zeiss 900 TEM. For scanning electron microscopy,
parasites were placed on a specimen support with poly-L-lysine, dehydrated in ethanol,
critical-point dried in CO2, coated with gold, and observed in a Shimadzu SS-550 SEM. The ultrastructural studies
on the epimastigote showed alterations in the mitochondria and cytoplasmatic extraction,
with multiple vacuoles. Observations by scanning electron microscopy revealed alterations
in the shape and size of the epimastigotes. These findings add a new insight in the
search for new antiprotozoal agents from natural sources.
Acknowledgements: This study was supported through grants from DECIT/SCTIE/MS and
MCT by CNPq, FINEP, and CAPES.
References: [1] Salas, C. et al. (2008) Bioorgan. Med. Chem. 16:668–674.
[2] WHO, Control of Chagas Disease (2002).
[3] Menna-Barreto, R.F. et al. (2009) Micron 40:157–168.